Constantiam Biosciences

Watertown, United States

Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.

Sep 2024

Grant

Bioinformatics Biotechnology Genetics Health Care Health Diagnostics

Top Investors

National Institute on AgingNational Human Genome Research Institute

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Constantiam Biosciences

Who are Constantiam Biosciences's investors?

Constantiam Biosciences's investors include National Institute on Aging, National Human Genome Research Institute.

Where is Constantiam Biosciences headquartered?

Constantiam Biosciences is headquartered in Watertown, United States.

What does Constantiam Biosciences do?

Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.

What stage is Constantiam Biosciences at?

Constantiam Biosciences is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 19, 2024.

MLA

"Constantiam Biosciences — Funding & Investors." VCBacked, September 19, 2024, https://www.vcbacked.co/company/constantiam-biosciences. Accessed July 1, 2026.

APA

VCBacked. (2024). Constantiam Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/constantiam-biosciences

Wikipedia (cite web)

{{cite web |title=Constantiam Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/constantiam-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 19, 2024.